Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.

Approximately 5%-10% of patients with diabetes are diagnosed with type 1 diabetes mellitus (T1DM), the incidence and prevalence of which is projected to increase through 2050. Despite this, T1DM-related health care resource utilization (HCRU) and economic burden in the United States have not been adequately assessed, since previous studies used various cost definitions and underlying methods to examine these outcomes. To assess HCRU and costs incurred by patients with T1DM in the United States.